Sana Biotechnology, Inc. (SANA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -37.38M | -32.64M | -29.43M | -33.1M | -48.66M | -47.16M | -51.82M | -58.54M | -65.63M | -51.96M | -63.55M | -58.8M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 23.18% | 30.79% | 43.21% | 43.46% | 25.86% | 9.23% | 18.46% | 0.44% | 17.21% | 31.69% | 1.92% | 17.74% |
| Net Income | -47.21M | -58.83M | -42.15M | -93.8M | -49.39M | -49.07M | -59.92M | -50.29M | -107.47M | -88.12M | 984K | -114M |
| Depreciation & Amortization | 2.39M | 3.05M | 3.2M | 2.86M | 3.65M | 5.69M | 4.06M | 3.9M | 3.75M | 7.54M | 4.5M | 4.45M |
| Stock-Based Compensation | 0 | 6.34M | 0 | 6.63M | 7.02M | 6.44M | 10.77M | 11.38M | 9.09M | 7.93M | 9M | 9.85M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.35M | 0 | 0 |
| Other Non-Cash Items | 13.95M | 13.38M | 8.83M | 55.8M | 919K | -14.49M | -6.38M | -25.87M | 36.47M | 34.79M | -83.21M | 26.91M |
| Working Capital Changes | -6.51M | 3.41M | 697K | -4.59M | -10.86M | 4.27M | -344K | 2.35M | -7.46M | 10.24M | 5.18M | 14M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 454K | -189K | -357K | 0 | -4.22M | 2.28M | -507K | 667K | -1.06M | -1.34M | 2.28M | 441K |
| Cash from Investing | 49.44M | -16.5M | -48.02M | 7.68M | 16.6M | 47.09M | 41.77M | 5.82M | -77.23M | 15.31M | 51.35M | 42.63M |
| Capital Expenditures | -288K | -873K | -41K | 112K | -136K | -436K | -4.09M | -13.06M | -15.85M | -14.05M | -2.23M | -1.58M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 248K | 635K | 136K | 0 | 253K | 0 | 0 | 0 | 0 | -29.36K | -53.58K | -44.2K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 26K | 0 | 7.57M | 0 | 0 | 0 | 0 | 0 | 29.36K | 53.58K | 44.2K |
| Cash from Financing | -128K | 17.65M | 109.54M | 561K | 982K | 643K | 2.08M | 10.63M | 186.4M | 1.72M | 187K | 29.5M |
| Debt Issued (Net) | -91K | -89K | -87K | -86K | -85K | -56K | 172K | 7.63M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 59K | 17.74M | 109.63M | 0 | -60K | -181M | -29K | 3M | 181.47M | 1.72M | -5K | 27.01M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -60K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -96K | 0 | 0 | 647K | 1.13M | 181.7M | 1.94M | 0 | 4.93M | 0 | 192K | 2.49M |
| Net Change in Cash | 11.93M | -31.49M | 32.09M | -24.86M | -31.07M | 570K | -7.96M | -42.1M | 43.54M | -34.93M | -12.02M | 13.33M |
| Free Cash Flow | -37.67M | -33.51M | -29.47M | -32.99M | -48.79M | -47.6M | -55.91M | -71.6M | -81.48M | -66M | -65.78M | -60.38M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 22.8% | 29.59% | 47.29% | 53.92% | 40.11% | 27.89% | 15.01% | -18.58% | -0.04% | 18.18% | 4.86% | 20.42% |
| FCF per Share | -0.14 | -0.13 | -0.11 | -0.14 | -0.21 | -0.20 | -0.24 | -0.31 | -0.37 | -0.33 | -0.33 | -0.31 |
| FCF Conversion (FCF/Net Income) | 0.79x | 0.55x | 0.70x | 0.35x | 0.99x | 0.96x | 0.86x | 1.16x | 0.61x | 0.59x | -64.58x | 0.52x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |